OCD Trial, Recruiting NCT06102941 Sponsor: Columbia University Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT06102941
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are between 8 and 12 years old
  • Children who have been formally diagnosed with OCD (obsessive-compulsive disorder) as their main and most troubling problem, confirmed through standardized assessments
  • Children whose OCD symptoms score at a certain level of severity on a standard rating scale (confirm with trial site)
  • Children who are not currently taking any psychiatric medications, or who have been off such medications for at least 3 months
  • Children who are not currently receiving any therapy or other treatment for OCD
  • Children and families who are able to go without other treatments during the study period (the only treatment would be the therapy provided by the trial)
  • Children who are able to give their agreement to take part in the study

Who may not be able to join:

  • Children who have been diagnosed with certain other mental health conditions, such as major depression, PTSD, psychosis, bipolar disorder, an eating disorder, or a developmental disorder (confirm with trial site for the full list)
  • Children who are currently having thoughts of suicide or self-harm
  • Girls who are pregnant or breastfeeding
  • Children who have a significant ongoing medical condition or neurological (brain or nervous system) problem, such as uncontrolled high blood pressure, seizures, or a history of serious head injury
  • Children whose urine test shows the presence of illegal drugs
  • Children who have any metal devices in their body or who wear dental braces
  • Children whose IQ is below 80

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rachel Marsh, Columbia University

Phone: 646-774-5868

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 June 2024
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

NIH Toolbox Cognition Battery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov